Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-09

Clinical Trial Update: Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial update examining the timing of D-Cycloserine to augment cognitive-behavioral therapy for social anxiety disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • D-cycloserine (D-cycloserine)

Snippet

Sponsor: University of Texas at Austin | Conditions: Social Anxiety Disorder | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2020-06-09